We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$1.53B
AUM Growth
+$224M
Cap. Flow
+$172M
Cap. Flow %
11.23%
Top 10 Hldgs %
40.36%
Holding
96
New
31
Increased
23
Reduced
14
Closed
23

Top Buys

Rank Stock Value
1
EPC icon
Edgewell Personal Care
EPC
+$50.2M
2
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$38.2M
3
SJM icon
J.M. Smucker
SJM
+$36.4M
4
INCY icon
Incyte
INCY
+$29.3M
5
TBPH icon
Theravance Biopharma
TBPH
+$28M

Top Sells

Rank Stock Value
1
FRPT icon
Freshpet
FRPT
+$51.6M
2
UTHR icon
United Therapeutics
UTHR
+$43.6M
3
CAKE icon
Cheesecake Factory
CAKE
+$37.1M
4
POST icon
Post Holdings
POST
+$29.7M
5
ASRT
Assertio
ASRT
+$28.4M

Sector Composition

Rank Sector Weight
1 Healthcare 37.79%
2 Consumer Discretionary 23.39%
3 Consumer Staples 8.62%
4 Communication Services 0.74%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AYTU icon
76
AYTU BioPharma
AYTU
$22.3M
– –
-375
Closed -$956K
CAKE icon
77
Cheesecake Factory
CAKE
$5.03B
– –
-700,000
Closed -$37.1M
CPB icon
78
Campbell Soup
CPB
$6.85B
– –
-628,000
Closed -$24.4M
FRPT icon
79
Freshpet
FRPT
$3.04B
– –
-2,416,000
Closed -$51.6M
HAPN
80
Happen Inc
HAPN
$2.14B
– –
-860,000
Closed -$15.1M
MDGL icon
81
Madrigal Pharmaceuticals
MDGL
$12.6B
– –
-102,000
Closed -$11.9M
PCRX icon
82
Pacira BioSciences
PCRX
$1.04B
– –
-726,671
Closed -$22.6M
POST icon
83
Post Holdings
POST
$4.42B
– –
-598,976
Closed -$29.7M
PULM icon
84
Pulmatrix
PULM
$6.1M
– –
-8,200
Closed -$835K
SAM icon
85
Boston Beer
SAM
$1.95B
– –
-128,000
Closed -$24.2M
SCYX icon
86
SCYNEXIS
SCYX
$37.4M
– –
-12,500
Closed -$1.34M
TSCO icon
87
Tractor Supply
TSCO
$16.3B
– –
-1,375,000
Closed -$17.3M
UAA icon
88
Under Armour
UAA
$3.01B
– –
-1,520,000
Closed -$24.9M
UTHR icon
89
United Therapeutics
UTHR
$26.1B
– –
-388,000
Closed -$43.6M
PRKS icon
90
CALL
United Parks & Resorts
PRKS
$2.19B
– –
-1,000,000
Closed -$14.8M
SEEL
91
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
– –
-17
Closed -$796K
ISEE
92
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-3,592,000
Closed -$9.84M
TLRD
93
DELISTED
Tailored Brands, Inc.
TLRD
– –
-800,000
Closed -$20M
HZNP
94
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-1,540,000
Closed -$21.9M
AVXS
95
DELISTED
AveXis, Inc. Common Stock
AVXS
– –
-88,000
Closed -$10.9M
1 2 3
4

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

Armistice Capital's Q2 2018 Portfolio in Review

As of Q2 2018, Armistice Capital held 96 positions worth $1.53B, up 17% from $1.31B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Armistice Capital deployed $172M of net new capital in Q2 2018, opening 31 new positions and adding to 23 existing holdings. Its largest new stake was Edgewell Personal Care: 1,092,000 shares worth $55.1M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 42% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Assertio, an estimated $28.4M trimmed.

  • Armistice Capital's largest Q2 2018 buy was Edgewell Personal Care: 1,092,000 shares worth $55.1M.
  • Armistice Capital added most to Despegar.com in Q2 2018, an estimated $25.3M increase.
  • Armistice Capital's biggest Q2 2018 reduction was Assertio, cutting an estimated $28.4M.
  • Armistice Capital fully exited Freshpet in Q2 2018, selling an estimated $51.6M.
  • Armistice Capital's ten largest holdings make up 40% of its $1.53B portfolio in Q2 2018.
  • Armistice Capital opened 31 new positions and closed 23 in Q2 2018.
  • Armistice Capital's portfolio value rose 17% quarter-over-quarter to $1.53B.

Based on Armistice Capital's 13F filing for Q2 2018, filed 14 Aug 2018.